![bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Item - Buthionine-[S,R]-sulfoximine (BSO) and](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Fbcj.2014.45/MediaObjects/41408_2014_Article_BFbcj201445_Fig6_HTML.jpg)
bso glutathione
Shipping Estimate
bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Item - Buthionine-[S,R]-sulfoximine (BSO) and
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
![bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Item - Buthionine-[S,R]-sulfoximine (BSO) and](https://s3-eu-west-1.amazonaws.com/ppreviews-plos-725668748/550659/preview.jpg)
![bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Item - Buthionine-[S,R]-sulfoximine (BSO) and](https://pbs.twimg.com/media/FOOP6CcXwAgMZep.jpg)
![bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Item - Buthionine-[S,R]-sulfoximine (BSO) and](https://ars.els-cdn.com/content/image/1-s2.0-S153561081400470X-fx1.jpg)
![bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Item - Buthionine-[S,R]-sulfoximine (BSO) and](https://ars.els-cdn.com/content/image/1-s2.0-S0048357520301279-ga1.jpg)
![bso glutathione The synthesis inhibitor buthionine sulfoximine synergistically enhanced melphalan activity against preclinical models of multiple myeloma Item - Buthionine-[S,R]-sulfoximine (BSO) and](https://media.springernature.com/lw685/springer-static/image/art%3A10.1038%2Femm.2017.15/MediaObjects/12276_2017_Article_BFemm201715_Fig3_HTML.jpg)
